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The anti-microbial functions of neutrophils are facilitated by a defensive armamentarium 
of proteins stored in granules, and by the formation of neutrophil extracellular traps 
(NETs). However, the toxic nature of these structures poses a threat to highly 
vascularized tissues, such as the lungs. Here, we identified a cell-intrinsic program that 
modified the neutrophil proteome in the circulation and caused the progressive loss of 
granule content and the reduction of the NET-forming capacity. This program was driven 
by the receptor CXCR2 and by regulators of circadian cycles. As a consequence, lungs 
were protected from inflammatory injury at times of day or in mouse mutants in which 
granule content was low. Changes in the proteome, granule content and NET formation 
also occurred in human neutrophils, and correlated with the incidence and severity of 
respiratory distress in pneumonia patients. Our findings unveil a “disarming” strategy of 





Neutrophils are endowed with highly specialized features to combat infections. They accumulate 
receptors, proteases, antimicrobial peptides and proteins inside cytoplasmic granules that 
mediate the production of reactive oxygen species (ROS) or DNA-based extracellular traps 
(NETs), both of which are highly toxic and allow for effective containment of pathogens 1, 2. 
Several types of granules coexist in the neutrophil cytoplasm 3, including primary (azurophilic) 
granules that store myeloperoxidase (MPO), secondary (specific) and tertiary (gelatinase) 
granules and secretory vesicles, each of which carries distinct types of cargo 1, 4. The different 
granules form at different stages of granulopoiesis in the bone marrow 5, 6, and the synthesis of 
granule proteins declines as neutrophils differentiate 7, 8. In contrast, receptors needed for 
sensing, migration and phagocytosis are mostly synthesized once they reach the circulation 7, 8.  
After only 6-10 hours in the circulation 9,  neutrophils rapidly disappear from blood 10, 11. 
However, this does not imply immediate elimination, as they can be found within the vessels or 
parenchyma of multiple organs, with a preference for the spleen, bone marrow and lungs 10. The 
homeostatic infiltration of granule-laden neutrophils, a process enabled by a cell-intrinsic 
program that relies on the chemokine receptor CXCR2 and the core clock protein Bmal112, can 
be potentially damaging to highly vascularized tissues such as the lungs. Indeed, lungs are 
highly susceptible to neutrophil-mediated damage that can cause respiratory dysfunction and 
death, as shown in murine models of lung injury 13, 14, 15. In humans, neutrophil-mediated acute 
vascular damage followed by pulmonary edema and distress is common in patients with 
underlying pneumococcal infections or other pre-existing conditions 13, 16. 
Here we investigated whether specific mechanisms prevent neutrophil-inflicted toxicity in 
tissues. We discovered that the neutrophil proteome spontaneously “disarms” as they lose 
granule content during their lifetime in circulation. This resulted in a blunted capacity to produce 
NETs, rendering the neutrophils less toxic before they reached tissues and protected the lungs 
from injury both in mice and in pneumonia patients.  
Results 
The neutrophil proteome changes during the day 
Neutrophils undergo transcriptional changes while in the circulation 12. However, because 
transcriptional changes take relatively long time (in the range of hours) and diurnal 
transcriptional programs in mouse neutrophils favor their migration into tissues, we deemed 
transcriptional regulation insufficient to protect the tissues from the toxic activity of neutrophils. 
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We undertook a proteomic approach to explore the changes in protein content in neutrophils at 
different times after release from the bone marrow. Because the number of neutrophils that can 
be purified from the blood of naïve mice at night (when neutrophils are released from the bone 
marrow) or at noon (when neutrophils have spent several hours in the circulation)17 is low, we 
increased the number of night-like neutrophils released from the bone marrow by a one-time 
intraperitoneal injection at zeitgeber time 4 (ZT4, or 4 hours after lights on) of AMD3100, an 
antagonist for CXCR4 that induces the rapid mobilization of neutrophils from the bone marrow 
18. To increase the number of day-like neutrophils in circulation we injected blocking antibodies 
against endothelial selectins (1mg/kg, intravenously at ZT5 at days -5, -3 and -1 before 
collection)12, 17 (Extended Data Fig. 1a). The proteomic analysis of these night- and day-like 
neutrophils isolated at ZT5 from the blood of wild-type mice yielded 6677 proteins 
(Supplementary Table 1). 171 proteins were differentially detected in one versus the other 
group, with proteins involved in regulation of the cytoskeleton (Arghdib,	Rufy3), adhesion 
(Thbs1, Itgam), inflammasome (Nlrp3, Nlrp4e) and vesicular transport (Vps33b; Fig. 1a) 
enriched in night-like neutrophils. The differential expression of identified proteins in night- 
versus day-like neutrophils, such as VEGFR1, CD74, CD16/32, CD63 or CD14, was confirmed 
by flow cytometry (Extended Data Fig.1b). Gene ontology analyses (Supplementary Table 2) 
indicated involvement of the differentially expressed proteins in immune defense, cytokine 
signaling and angiogenesis (Extended Data Fig.1c). Night-like neutrophils were enriched for 
pathways linked to c-Kit signaling and platelet production, possibly reminiscent of their time in 
the bone marrow, as well as GTPase Rho signaling (Fig. 1b), consistent with the enhanced 
migratory capacity of “younger” neutrophils 12. Day-like neutrophils showed upregulation of 
protein synthesis, pathogen sensing and respiration (Fig. 1b), suggesting specialization for 
effector functions and enhanced TLRs signaling, as suggested 12, 19. Comparison of the 
neutrophil proteome with transcriptional datasets associated with diurnal time12 showed poor 
correlation (Extended Data Fig. 1d), suggesting that the proteomic changes are not driven by 
direct transcriptional regulation. These results therefore identify prominent changes in the 
neutrophil proteome that are associated with the time spent in the circulation. 
 
Circulating neutrophils degranulate in the steady-state 
The proteomic data indicated that proteins stored in the various types of granules (azurophilic, 
specific and tertiary/gelatinase granules) were enriched in night-like neutrophils (Fig. 1c and 
5 
 
Supplementary Table 3). An enrichment in granule proteins was also detected in the proteome 
of circulating neutrophils from AMD3100-mobilized mice compared to day-time neutrophils 
(Extended Data Fig. 1e,f and Supplementary Table 4). Further analysis in the Reactome 
database indicated that proteins differentially detected in the night- vs. day-like groups were 
associated with degranulation (Extended Data Fig. 2a), altogether suggesting progressive loss 
of granules as neutrophils circulate. 
Cytometric analysis of WT circulating neutrophils purified every 4 hours (daytime ZT1, 5 and 9; 
nighttime ZT13, 17 and 21) revealed circadian oscillations of side-scatter properties, a feature 
that reflects cell granularity (Extended Data Fig. 2b). To assess if these variations in side-
scatter were caused by degranulation, we stained cytospins of Ly6G+ blood neutrophils purified 
at the same times as above for MPO, a protein of azurophilic granules, and analyzed granule 
content by high-resolution confocal microscopy (Fig. 1d). The maximal abundance of MPO+ 
granules was observed at ZT17 (midnight, when neutrophils leave the marrow), while the valley 
was at ZT1 (Fig. 1e and Extended Data Fig. 2c), indicating progressive loss of primary 
granules. MPO+ granule content in neutrophils was in anti-phase with elastase activity in 
plasma (Fig. 1f), suggesting release of granule content into blood. A 12-hour shift in the animal 
light cycle for three weeks completely re-adjusted the pattern of granule content in neutrophils 
(Extended Data Fig. 2d), indicating that degranulation was circadian in nature. Finally, Ly6G+ 
neutrophils from lungs, spleen and liver had a lower MPO+ granule content compared to Ly6G+ 
neutrophils in the blood (Extended Data Fig. 2e-f), altogether suggesting that neutrophils 
undergo homeostatic degranulation in the circulation before they enter tissues. 
 
Neutrophils progressively lose NET-forming capacity  
Proteases stored in the azurophilic granules degrade the nuclear histones and promote 
chromatin decondensation during NET formation 20 and granule proteins have been identified in 
the NET proteome 21. Among the proteins found in the proteomic analyses, those associated 
with NETs (Supplementary table 3) were enriched in the proteome of night-like neutrophils 
(Fig. 2a), suggesting that NET release is more prevalent at this time. To directly examine 
whether the formation of NETs varied during the course of a day, we treated Ly6G+ neutrophils 
purified at ZT5 or ZT13 from the blood of WT mice with phorbol myristate acetate (PMA), a 
NET-inducing compound, and analyzed for the presence of extracellular DNA decorated with 
MPO protein and citrullinated histone 3 (cit-H3). We found that neutrophils at night (ZT13) 
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formed more NETs than at daytime (ZT5) (Fig. 2b), revealing a correlation between diurnal 
azurophilic granule content and NET-forming capacity in blood Ly6G+ neutrophils. Next, we 
assessed the presence of NETs by whole mount immunostaining with the same markers in 
cremaster muscles of wild-type and Lyz2CreMcl1fl/fl mice (which are neutropenic22) after 
ischemia-reperfusion. Many more NETs were detectable in the muscles of mice at ZT13 than at 
ZT5, while no NETs were detected in the Lyz2CreMcl1fl/fl mice (Fig. 2c). Thus, proteomic 
changes and degranulation of circulating neutrophils temporally coincide with loss of NET-
forming ability.  
	
Proteome changes are driven by CXCR2 and Bmal1 
Diurnal changes in neutrophil transcription and migration are controlled by a cell-intrinsic 
mechanism, in which the expression of the chemokine Cxcl2 is regulated by the molecular clock 
protein Bmal1 and leads to the cell-autonomous, diurnal activation of neutrophils by signaling 
though CXCR212. We therefore tested whether this mechanism caused the proteome changes. 
Treatment with CXCL2 induced degranulation in isolated wild-type Ly6G+ circulating neutrophils 
(Fig. 3a). Analysis of the granule content of blood neutrophils at ZT5 and ZT13 from MRP8CRE 
Cxcr2fl/fl (referred to as CXCR2N hereafter)12, which have a neutrophil-specific deficiency in 
CXCR2, showed no differences in MPO+ granule content or in side scatter properties in blood 
neutrophils, compared with neutrophils from wild-type mice (Fig. 3b and Extended Data Fig. 
2b). CXCR2N neutrophils degranulated in response to PMA and LPS (Extended Data Fig. 3a-
b), indicating that degranulation could be otherwise induced in these cells. We also found a loss 
of diurnal oscillations in granule content in blood neutrophils from Cxcl2mice (Fig. 3b). 
Neutrophils from CXCR2N and Cxcl2mice also showed no differences in NET formation 
between ZT5 and ZT13 (Fig. 3c). In chimeric mice transplanted with equal mixes of bone 
marrow from DsRed+ wild-type and Cxcl2 mice, Cxcl2 neutrophils had a higher granule 
content than wild-type neutrophils analyzed at the same time (ZT5; Fig. 3d), suggesting that 
CXCL2 signaled in neutrophils in an autocrine fashion to control granule content. 
Circadian expression of Cxcl2 in neutrophils is controlled by the transcription factor Bmal112. 
MRP8CRE Arntlfl/fl mice, which have a neutrophil-specific deletion of Arntl (which encodes Bmal1, 
referred hereafter as Bmal1N) showed no circadian differences in MPO+ granule content 
between ZT5 and ZT13 (Extended Data Fig. 4a) and NET formation (Extended Data Fig. 4b) 
in purified Ly6G+ neutrophils from blood compared to neutrophils from wild-type controls, 
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suggesting that Bmal1 controlled the changes in the neutrophil proteome. Proteome analysis in 
Ly6G+ neutrophils purified at ZT5 (day) or ZT13 (night) from the blood of Bmal1N mice 
(Extended Data Fig. 4c and Supplementary Table 5) indicated that Bmal1N neutrophils did 
not show circadian changes in granule proteins or in NET-associated proteins (Extended Data 
Fig. 4d-e). These data indicated that Bmal1 and signaling through CXCL2-CXCR2 controlled 
the changes in granule content and the loss in the capacity to form NETs in neutrophils. 
	
The severity of lung injury varies during the day  
To test whether the diurnal changes in the neutrophil proteome influenced the outcome of 
inflammatory responses in tissues, we used a model of endotoxin and antibody-induced acute 
lung inflammation (ALI)15, 23, which is dependent on neutrophils and NETs 24, 25, 26 and 
recapitulates the pulmonary injury observed in transfused patients 27. We used ALI-prone Balb/c 
mice, which displayed normal diurnal variations in neutrophil number and phenotype (Extended 
Data Fig. 5a-c) 12. 
Lungs from Balb/c mice treated to induce ALI (by intraperitoneal injection of 0.1mg/kg LPS 24 
hours before intravenous injection of 0.5 mg/kg of an anti-H2d antibody) showed evidence of 
NETs defined by staining for MPO, DNA and cit-H3 (Fig. 4a, Movie 1 and  Movie 2)24, 26. To 
assess the kinetics of NET formation in vivo during ALI, we performed high-speed multichannel 
intravital imaging of the lung microcirculation 28. Neutrophils were identified by Ly6G staining, 
while NET-like structures where identified by the rapid extrusion of Sytox-green-labelled DNA 
from Ly6G+ neutrophils, as a result of intravenous injection of the dye 5 minutes before imaging 
(Fig. 4b and Movie 3). The Sytox-green+ extrusions were inhibited by the PAD4 inhibitor Cl-
amidine injected intravenously one hour before ALI induction (Fig. 4c), indicating that they 
represented NETs. Continuous tracking of neutrophil behavior for 40 minutes showed higher 
release of Sytox-green+ extrusions at ZT13 compared with ZT5 (Fig. 4c and Movie 3). The 
enhanced NET production at night was detectable minutes upon induction of ALI and was 
sustained for the rest of the experiment (Fig. 4c). In contrast, the number of Ly6G+ neutrophils 
was similar at ZT5 and ZT13 in untreated and in Cl-amidine-treated mice (Extended Data Fig. 
6a-c). Because platelets have been involved in neutrophil activation and NET formation during 
ALI 15, 25, we assessed their possible involvement in the observed differences between ZT5 and 
ZT13. We found a sharp increase in the number of platelets in the pulmonary vessels in mice 
with ALI, however their numbers were comparable at ZT5 and ZT13 (Extended Data Fig. 6b), 
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suggesting that the number of neutrophils or platelets did not influence the diurnal changes in 
pulmonary NET-formation. 
To evaluate the effects of the diurnal changes in NET formation in the inflamed lungs, we 
measured the kinetics of edema formation, which is caused by infiltration of plasma in the 
alveolar space. Intravenous injection with Evan’s blue after ALI induction at ZT5 indicated a 
marked increase in pulmonary vascular permeability during ALI, compared to LPS-only treated 
controls (Extended Data Fig. 7a), which was specific to the lungs. We then used computerized 
tomography (CT) to track the in vivo dynamics of edema in mice in which we induced at ZT5 
(day) or at ZT13 (night). We found a rapid and sharp increase in water content of the lungs, 
which occurred earlier and was higher in ZT13- compared with ZT5-induced mice (Fig. 4d, e). 
This correlated with reduced survival of mice in which ALI was induced at ZT13 compared to 
those induced at ZT5 (Fig. 4f). Finally, treatment with Cl-amidine one hour before induction at 
ZT5 protected mice from edema and death (Fig. 4e, f), indicating that the release of NETs was 
a primary cause of ALI. Thus, the severity of lung injury during ALI displays diurnal patterns that 
correlate with granule content and capacity to form NETs by neutrophils. 
 
Variations in the neutrophil proteome drive lung injury  
To assess whether neutrophil-intrinsic variations in granule content and NET formation caused 
lung inflammation, we used Bmal1N  mice and MRP8CRE Cxcr4fl/fl, which lacked CXCR4, a 
negative regulator of CXCR2 signaling12, specifically in neutrophils (hereafter CXCR4N). 
Neutrophils from Bmal1N and CXCR4N mice share transcriptional and migratory properties with 
night and day neutrophils, respectively12. MPO immunofluorescence and transmission electron 
microscopy imaging of Ly6G+ blood neutrophils purified at ZT5 revealed higher azurophilic 
granule content in Bmal1N neutrophils compared with wild-type neutrophils, and comparable to 
that of wild-type neutrophils at ZT13 (Fig. 5a,b). In contrast, CXCR4N neutrophils at ZT5 had 
strong reductions in azurophilic granule content compared with WT neutrophils at any time point 
(Fig. 5a, b). NET formation in response to PMA was elevated in Bmal1N neutrophils obtained at 
ZT5, and strongly reduced in CXCR4N neutrophils, relative to wild-type cells at ZT5 (Fig. 5c). 




To test whether the diurnal changes in the susceptibility to ALI were caused by changes in 
neutrophil granularity, we analyzed the responses of Bmal1N and CXCR4N mice to induction of 
ALI at ZT5. Intravital microscopy analyses showed faster and elevated NET formation in the 
lungs of Bmal1N mice, compared with lungs of CXCR4N mice, which were similar to the 
differences found at ZT13 and ZT5, respectively, in wild-type mice (Fig. 5d). Intravital 
microscopy and flow cytometry showed similar numbers of neutrophils and platelets, as well as 
the number of interactions with each other, within the microvasculature of wild-type, Bmal1N 
and CXCR4N mice (Extended Data Fig. 6d-g), indicating an otherwise normal behavior of 
intravascular neutrophils in these mice. We found dramatically elevations in pulmonary edema 
and reduced survival in Bmal1N mice during ALI induced at ZT5, compared with CXCR4N mice 
(Fig. 5e,f and Movie S4). The protection from pathology correlated with preservation of vascular 
permeability in the lungs of CXCR4N mice after intravenous injection of Evans blue (Extended 
Data Fig. 7b,c). Intravital imaging in wild-type mice allowed visualization of two distinct NET-like 
formation events, “flowing” NETs, in which the extruded NETs were immediately washed away 
by the bloodstream, and “adherent” NETs, in which the extruded DNA remained adherent to the 
vasculature (Extended Data Fig. 7d and Movie S5). In Bmal1N mice, the frequency of 
adherent NETs was elevated compared with flowing NETs, but not in wild-type or CXCR4N 
mice (Extended Data Fig. 7e), suggesting that the ability of neutrophils to deposit NETs onto 
the endothelium enhanced vascular damage in Bmal1N mice. 
Next, we tested the causal relationship between the diurnal proteome changes in neutrophils 
and the diurnal susceptibility to inflammation in the Bmal1N mice. Neutrophils from Bmal1N 
mice had a constitutively high MPO+ granule content and NET-forming capacity (Extended 
Data Fig. 4a,b), and reduced survival during ALI at both  ZT5 or ZT13 (Extended Data Fig. 8a). 
CXCR4N neutrophils, in turn, had a similar loss in circadian granule content and NET formation 
(Extended Data Fig. 8b,c), and higher survival during ALI at both ZT5 or ZT13 (Extended Data 
Fig. 8a). Of note, the number of circulating neutrophils in Bmal1N mice oscillated during the 
day, similar to wild-type mice (Extended Data Fig. 8d), whereas CXCR4N mice display 
constitutively high neutrophil counts12, indicating that the granule content, but not the number of 
neutrophils, was associated with the severity of pulmonary inflammation. These observations 
indicated that impaired diurnal changes in the proteome and the granule content in neutrophils 




Human neutrophils undergo proteome disarming 
Clinical manifestations of inflammation display circadian oscillations in humans, and are 
associated with time-of-day variations in both the incidence and the severity of cardiovascular 
disease 29, 30, 31. We tested whether neutrophil “disarming” in humans could underlie the 
circadian changes in vascular inflammation. In 10 healthy volunteers we measured neutrophil 
counts in blood and performed proteomic analysis, granule content and NET formation assays 
in neutrophils isolated at 8 am, 2 pm and 7 pm (Extended Data Fig. 9a), when diurnal patterns 
in neutrophil number and phenotype are prominent in humans12. Human neutrophils display a 
night-like phenotype (similar to murine ZT13) early in the morning and progress towards a day-
like phenotype (similar to murine ZT5) over the next 4-8 hours 12. In our cohort, neutrophil 
counts increased over time and peaked at 2-7 pm (Fig. 6a), while the granularity of neutrophils, 
indicated by the side scatter by flow cytometry, decreased from 8 am to 7 pm (Fig. 6b). Direct 
examination of granules in human neutrophils stained for MPO (Fig. 6c-d), as well as by TEM 
imaging (Fig. 6e), indicated a diurnal reduction in granule content, which peaked at 8 am and 
showed a trough at 2 pm.  
Proteomic analyses of neutrophils isolated in density gradients at 8 am and 2 pm from the blood 
of 5 healthy volunteers (Supplementary Table 6) indicated that, from a total of 1918 proteins 
detected, around 9.7% were differentially enriched when comparing 8am versus 2pm (p< 0.05; 
Fig. 6f). Gene ontology analyses revealed that the differentially detected proteins were in 
pathways related to vesicle-mediated transport, secretion, exocytosis or degranulation 
(Extended Data Fig. 9b and Supplementary Table 7), consistent with a loss of granule 
content in human neutrophils over time. Many of the individual proteins identified in the mouse 
analyses were not detected, or did not show diurnal changes, in the human samples (not 
shown), probably indicating a high variability among human individuals compared with co-
housed and strain-matched mice. However, numerous granule proteins, such as MPO, MMP9, 
or LTF, were more abundant at 8am than at 2 pm in human neutrophils (Fig. 6g). Similar to 
mouse neutrophils, there was a poor correlation between transcript and protein amounts in 
human neutrophils (Extended Data Fig. 9c), suggesting that the proteomic changes were 
largely independent of transcriptional regulation. Ex vivo assays of human neutrophils purified 
using density gradients and treated with vehicle or PMA indicated a marked reduction in NET-
forming capacity between 8 am and 2 pm (Fig. 6h-i), corresponding with more NET-related 
proteins at 8am compared to 2 pm (Extended Data Fig. 9d). These observations suggested 
that diurnal degranulation also occurred in circulating human neutrophils. 
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We finally tested whether the changes in proteome, granule content and NET-forming activity in 
human neutrophils were associated with variations in the susceptibility to develop inflammation, 
and/or its severity. We focused on an existing cohort of 5334 patients with community-acquired 
pneumonia (CAP), which are at risk of developing acute respiratory distress syndrome (ARDS) 
32. Retrospective analysis of the human cohort indicated that, among the patients hospitalized 
with CAP, 125 (2.3%) developed ARDS. Assessment of the temporal patterns of disease onset 
and severity (using the pneumonia severity index) by plotting the times of admission against the 
pneumonia index and death in this subset of patients revealed consistent diurnal oscillations, 
with a peak around 9 am and a trough at 5-7 pm for both parameters (Fig. 6j). These 
observations indicate that proteomic disarming occurs in human neutrophils and may influence 
the incidence and severity of inflammation (Extended Data Fig.10 and MovieS6). 
 
Discussion 
Here, we describe the existence in neutrophils of a cell-intrinsic program that induced the 
progressive loss of granule proteins involved in inflammation and the formation of NETs and 
provided a previously unrecognized layer of protection against the toxic activity of these 
leukocytes. The phenomenon of proteome disarming described herein shared key features with 
the process of neutrophil “aging” 12, in terms of reliance on CXCR2 signaling, regulation by 
Bmal1 and CXCR4 in a cell-intrinsic manner and similar temporal patterns (i.e., peak at noon). 
This suggested that neutrophil aging and disarming might represent distinct manifestations of a 
core circadian program in neutrophils that allows anticipation of potential threats12, but also 
protects from excessive inflammation, vascular damage and death.  
Beyond regulating the magnitude of inflammation, changes in the neutrophil proteome displayed 
temporal oscillations that aligned neutrophil activity with circadian cycles. The circadian 
transcriptional regulation of migration-associated genes by Bmal1 controls the migratory 
properties of neutrophils, and allows the infiltration of naïve tissues in anticipation of potential 
infections 12. In addition to these transcription-mediated mechanisms, we uncovered here that 
the neutrophil proteome is also subject to circadian regulation, which blunts the ability of 
neutrophils to release toxic mediators and to produce NETs. This level of immune regulation 
may be particularly relevant for granulocytes, a group of innate immune cells that synthesize 
and store the majority of their early-response mediators inside dedicated organelles. Because 
the formation of granules and their content occurs as neutrophils differentiate in the bone 
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marrow 7, 33, it is unlikely that changes of the granule proteome that occur in the circulation are 
transcriptionally regulated, as illustrated by the poor correlation between the proteome and the 
transcriptome in these cells. Our data, however, suggested a model in which upstream control 
of transcription of Cxcl2 by Bmal1 12 allowed indirect regulation of the neutrophil proteome by 
the canonical circadian machinery. Conceptually, the temporal nature of this process in blood 
aligns with the evolutionary value of circadian oscillations in segregating mutually antagonistic 
processes, in this case potent anti-microbial responses and protection of the host against 
immune-mediated damage. 
The circadian patterns in the granule content and elastase activity in plasma suggested the 
progressive discharge of granules while in the circulation, such that neutrophils that migrate into 
tissues during the day 10 would have lost part of their anti-microbial arsenal, and would be as 
such less likely to elicit organ damage, as shown in the mouse model of ALI. Because 
neutrophil proteases are also important for the activation of many biological mediators, including 
cytokines, chemokines, growth factors and adhesion and pattern-recognition receptors 34, 35, and 
even modulate signaling cascades in other cells 36, 37, the programmed proteome changes 
reported here may have pleiotropic consequences in physiology. For instance, it predicts that 
neutrophils that are newly released from the bone marrow in conditions of stress, such as 
obesity or cancer 38, 39, may be better suited to regulate physiological aspects of target organs 
than the aged neutrophils that enter the tissues at the end of their life cycle and have lost part of 
their cargo. 
Our observations shed light into the particular susceptibility of the lungs to diurnal inflammation. 
Large numbers of neutrophils accumulate within the pulmonary microcirculation in mice, rabbits 
and non-human primates after stimulation or in the steady-state 10, 18, 40, and the lungs can 
provide a niche for effective anti-microbial responses 41. The homeostatic accumulation of 
neutrophils in the lungs at the end of the light cycle in mice 10 would predict higher susceptibility 
to inflammatory stimuli at this time. However, we found that neutrophils recovered from naïve 
lungs had reduced granularity, and that mutant mice with constitutive low levels of granules in 
neutrophils displayed permanent protection from ALI, suggesting a dominant contribution of the 
disarming process in tissue protection. 
It has long been recognized that multiple inflammatory processes in humans display circadian 
periodicity 42, and experimental models and retrospective studies have corroborated that not 
only the onset of inflammation, but also the severity of the inflammatory events manifest diurnal 
oscillations 31. These events are often caused by neutrophil activation and by thrombosis, which 
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in turn can be exacerbated in the presence of neutrophils or NETs 15, 25, 43, 44. Thus, our current 
findings in the context of ALI may extend to other inflammatory and thrombotic conditions 
affecting multiple organs, and suggest that interventions aimed at inducing controlled 




The Supplementary Information file contains Extended Data Figures 1-10 and legends for Movies 
S1-6 and Supplementary Tables 1-8. 
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Figure 1. Diurnal changes in the neutrophil proteome. 
a, Volcano plot of total the total proteome showing proteins with a False Discovery Rate (FDR) < 
0.01 (calculated as stated in methods section, from single samples of 60 million neutrophils 
pooled from 9 mice (night) and 6 mice (day). A positive Z-score represents an increase in 
nighttime (fresh) over daytime (aged) neutrophils. Color represents the functional category for 
each protein (legend, top-right). b, Gene-set enrichment analysis of the proteomics data showing 
pathways with a p-value < 0.15 enriched in aged (red) or fresh (blue) neutrophils. Size of the 
bubble-plot represents overlap between query and gene-set (legend bottom-right). c, Volcano plot 
of the proteomic dataset showing granule proteins with a Z-score > 2. Colors show the granule 
type for each protein (top right). d, Z-stack maximum projection of neutrophils stained for primary 
granules with MPO and counterstained with DAPI. e, Quantification of neutrophil granule contents 
during a full diurnal cycle. Curves are repeated (dashed line) to better appreciate the circadian 
pattern. Dark phase is shown in grey; n=30 cells per time point. f, Neutrophil elastase activity in 
plasma. Curves are repeated (dashed line) to better appreciate the circadian pattern. Dark phase 
is shown in grey; n=4 mice per time point. Data in e and f, are shown as mean ± SEM, and 
circadian oscillation p-values were determined by amplitude vs. zero two-tailed two-tailed t-test 
analysis (see Methods). 
 
Figure 2. Diurnal loss of NET-forming capacity. 
a, Volcano plot of the neutrophil proteome showing proteins found in NETs (red dots), and 
enrichment of these proteins in nighttime neutrophils. b, Ex vivo NET-formation assay. 
Neutrophils sorted at ZT13 (nighttime) or ZT5 (daytime) were stimulated with PMA or vehicle to 
induce NETs and stained for citrunillated-histone 3 (Cit-H3) and DNA (left). Colocalization of both 
markers was used to quantify NET formation as shown in the bar graph (right); n=3 mice per time 
point. c, Representative images (left) and quantification (right) of in vivo NET formation in the 
cremaster muscle subjected to ischemia/reperfusion at nighttime (ZT13), or at daytime (ZT5). 
Triple colocalization of MPO, DNA and Cit-H3 was used to define and quantify the area of NETs 
(red; arrowheads). Neutropenic Mcl1∆N mice (Lyz2Cre; Mcl1fl/fl mice) were used as controls and 
showed no NETs. Dotted areas are showed magnified in bottom panels; n = 3 mice per condition. 
Scale bars, 50 m. Bars show mean ± SEM. *; p<0.05; n.s., not significant, as determined by 
unpaired two-tailed t-test analysis. 
 
 
Figure 3. Degranulation and loss of NET-forming capacity are driven by CXCL2/CXCR2 
signaling.  
a, Ex-vivo stimulation of sorted neutrophils with CXCL2 induces degranulation (right), as 
quantified by confocal imaging of MPO-stained neutrophils (left); n = 29 (--) and 32 (+) cells. b, 
Diurnal quantification of granule content in neutrophils from WT, CXCR2∆N or CXCL2 mice, 
showing a loss of diurnal fluctuation in CXCR2-deficient (n = 38 cells at ZT5 and 40 cells at ZT13) 
or CXCL2-deficient neutrophils (n = 31 cells at ZT5 and 14 cells at ZT13), compared to their WT 
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counterparts (n = 30 cells at ZT5 and 34 cells at ZT13). c, Ex-vivo NET formation assays with 
sorted neutrophils stimulated with PMA or vehicle control, at nighttime (ZT13) or daytime (ZT5). 
NETs were quantified by triple-colocalization of citrunillated-histone 3, DNA and MPO in confocal 
micrographs (left; scale bar, 25 m). Each mouse was normalized to its vehicle control and NET 
formation at ZT13 and ZT5 compared (right). CXCL2-deficient (n = 3 mice per time) and CXCR2-
deficient (n = 6 mice at ZT5 and 2 mice at ZT13) neutrophils showed loss of diurnal fluctuation in 
NET formation compared with WT cells (n = 6 mice at ZT5 and 4 mice at ZT13). d, CXCL2 
signaling causes degranulation cell-autonomously, as shown by analysis of MPO+ granules in 
neutrophils from BM chimeras reconstituted with DsRed+ wild-type and DsRedNEG Cxcl2 
donors; scale bar, 5 m; n = 3 mice. Bars show mean ± SEM. **; p<0.01; n.s., not significant, as 
determined by paired (a,d) or unpaired (b-c) two-tailed t-test analysis. 
 
Figure 4. Diurnal loss of NET formation and pulmonary protection during ALI.  
a, Presence of NETs in lungs. Shown are maximum projections of confocal Z-stack series of 
cleared lungs from control mice (Basal) or mice with antibody-induced acute lung injury induction 
(ALI). Lungs were stained against citrunillated-histone 3, MPO and DNA, and some NETs are 
shown (arrowheads). Scale, 30 m. Representative images of n = 3 cleared lungs per condition. 
b, Time-series of 4D intravital imaging captures of NET-like structures in the lungs of ALI-induced 
mice. NET-like structures were defined as free DNA extruded out of Ly6G+ neutrophils. See also 
Movie 1. c, Quantification of NET-like structures as shown in b, and normalized to the number of 
neutrophils in mice in which ALI was performed at nighttime (ZT13, blue line) or daytime (ZT5, 
red line), or in mice treated with Cl-amidine (at ZT5, dashed gray line). Time course (left panel) 
and area under the curve values (right panel); in both, n = 15 fields from 4 mice per condition. 
Individual data points are not shown here as this graph uses a mean ± SEM value for the area 
under the curve calculated from the data shown in the left panel. d, Representative images of 
longitudinal CT series of edema formation at 0 or 21 min after inducing ALI ZT13 or ZT5. Note 
the increased edema (red) at night. Background bone signal (grey) is shown for anatomical 
positioning. e, Quantification of the images in d. Volume of edema was increased at ZT13 (blue; 
n = 7 mice) relative to ZT5 (red; n = 7 mice). Mice treated with Cl-amidine are shown as a control 
(grey, n = 4 mice). f, Survival of mice subjected to ALI at ZT13 (blue, n = 18 mice) or ZT5 (red, n 
= 21 mice), or treated with Cl-amidine (gray, n = 11 mice). Data are shown as mean ± SEM. **; 
p<0.01; ***, p<0.001, as determined by one-way ANOVA with Dunnet’s multiple comparison test 
(c), two-way ANOVA (eE) or log rank (two-tailed Mantel-Cox) test (f). 
 
 
Figure 5. Diurnal degranulation and pulmonary protection is neutrophil-intrinsic. 
a, Confocal micrographs and quantification of primary granules in neutrophils from WT mice at 
night (ZT13, n = 33 cells from 3 mice) or daytime (ZT5, n = 30 cells from 3 mice), and from mutant 
mice (n = 50 cells from 3 CXCR4∆N mice and 41 cells from 3 Bmal1∆N mice, both at ZT5); scale, 
2 m; b, Transmission electron microscopy images (left), and quantification of electrodense 
azurophilic granules (right) in WT and mutant mice (all at ZT5), showing increased granule content 
in Bmal1∆N, and reduced in CXCR4∆N neutrophils compared with WT cells; n = 19 cells from 3 
mice each; scale, 1 m. c, Ex vivo NET formation in sorted WT, Bmal1∆N or CXCR4∆N neutrophils 
stimulated with PMA or vehicle as control; n = 3 mice per condition. d, Quantification of NET-like 
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structures normalized to the number of neutrophils during ALI in Bmal1∆N (purple line) or CXCR4∆N 
(blue line) mice. Time course and elevations from baseline (gray area) are shown in the left panel, 
and the areas under the curve are shown in the right panel (Individual data points are not shown 
here as this graph uses a mean ± SEM value for the area under the curve calculated from the 
data shown in the left panel). Experiments were performed at ZT5. Data from wild-type mice at 
ZT5 (light gray, dashed) and ZT13 (dark gray, dashed) from Fig. 4c are shown for reference; n = 
15 fields from 3 mice for each condition. e, Representative images of longitudinal CT series of 
edema (red) in mutant mice subject to ALI (left) at ZT5, and quantification of the edema volume 
over time (right panel); n = 7 mice per genotype. f, Survival curves of Bmal1∆N (n = 19 mice) and 
CXCR4∆N (n = 12 mice) mice subjected to ALI at ZT5. Data are shown as mean ± SEM. *; p<0.05; 
**, p<0.01; ***, p<0.001; n.s., not significant, as determined by one-way ANOVA with Dunnet’s 
multiple comparison test (a-d), two-way ANOVA (e) or two-sided log rank (Mantel-Cox) test (f). 
 
Figure 6. Evidence for neutrophil disarming and pulmonary protection in humans.  
a, Blood neutrophil counts in human volunteers at the different time points; n = 10 human 
volunteers per timepoint. b, Light scattering (SSC-A) values for human neutrophils at different 
times, as measured by flow cytometry; n = 10 human volunteers. c, Quantification of primary 
granules from confocal images of human neutrophils from images in d; n = 150 cells from 10 
volunteers per time point. d, Representative images of granule content of human neutrophils, 
quantified in c. e, Transmission electron micrographs (left) of human neutrophils in the morning 
(8 am) and early afternoon (2 pm), and quantification (right) showing reduced numbers of 
electrodense primary granules; n = 33 cells from 3 human volunteers per time point. f, Volcano 
plot of the human neutrophil proteome analyzed at 8am and 2pm, showing proteins with p-value 
< 0.001 (see Methods section for human TMT proteomics). A negative Z-score represents higher 
values at 8am over 2pm neutrophils. n = 5 per time point. g, Volcano plot of granule proteins in 
the human neutrophil proteome, showing higher content in granule proteins (color-coded) at 8 am 
compared with 2 pm; n = 5 samples from healthy volunteers. Red dots and labels show 
differentially expressed proteins with p-value<0.05, and black dots show all granule proteins. 
Label color indicates the granule type in which the protein is normally found (top right). h, 
Representative confocal images and i, quantification of ex vivo NET formation by human 
neutrophils stimulated with PMA or vehicle at the indicated time points. n = 10 volunteers per time 
point. j, Acute respiratory distress syndrome (ARDS) severity shown as the pneumonia severity 
index (left) and intra-hospitalary deaths (right), of patients entering the ICU at different times of 
the day; n = 125 patients. Data are shown as mean ± SEM. **; p<0.01, as determined by unpaired 
two-tailed t-test analysis (f). P values for the circadian plots were calculated by the amplitude vs. 
zero two-tailed t-test analysis (a-c, g, i). Maroon line in a-c, g and i shows the non-linear COSINOR 







All experiments were performed in 7-18 weeks old male C57BL/6 or Balb/c mice kept in a 
specific pathogen-free facility at Centro Nacional de Investigaciones Cardiovasculares (CNIC) 
under a 12h light/12h dark schedule (lights on at 7am, off at 7pm), with water and chow 
available ad libitum. Bmal1∆N, CXCR4∆N and CXCR2∆N mutants in the C57BL/6 background 
have been described 12. For the ALI experiments, Bmal1∆N and CXCR4∆N mice were 
backcrossed into the Balb/c background for at least 6 generations and we confirmed 
susceptibility to antibody-induced lung injury at this stage (not shown). All procedures with 
backcrossed mice were controlled using Cre-negative littermates. For bone marrow transplant 
experiments, WT donor bone marrow came from mice expressing DsRed under the control of 
the β-actin promoter (DsRedTg). No specific randomization method was followed in this study. 
All experimental procedures were approved by the Animal Care and Ethics Committee of CNIC 
and the regional authorities. 
Proteomic analysis of fresh and aged mouse neutrophils with 18O 
Neutrophils were obtained from the blood of C57BL6 mice using different strategies. For night-
like neutrophils, mice were treated with AMD3100 (2.5 mg/kg i.p.) 1h before collection. For day-
like neutrophils, mice were treated with anti-P/E-selectin antibodies (1mg/kg i.v.) for 5d, every 
other day, before collection. Blood was obtained by collection in EDTA tubes to prevent 
coagulation. RBCs were precipitated using methylcellulose and leukocytes in the top phase 
were collected and washed before purification by negative selection. Negative selection was 
performed by incubation with biotinylated antibodies against CD3e, TER119, B220, CD8, 
CD115, CD4, CD49b and CD117, then incubated with streptavidin-coated beads and applied in 
a magnet for negative selection of neutrophils. We obtained neutrophils with a purity over 84%. 
60 million neutrophils from each source were obtained for analysis. 
After in-gel trypsin digestion, the “night-like” samples were equally mixed with the “day-like” 
samples which were labelled with 18O. The resulting tryptic peptide mixtures were subjected to 
nano-liquid chromatography coupled to mass spectrometry for protein identification. Peptides 
were injected onto a C-18 reversed phase (RP) nano-column (75 μm I.D. and 50 cm, Acclaim 
PepMap100, Thermo Scientific) and analyzed in a continuous acetonitrile gradient consisting of 
0-30% B in 240 min, 30-90% B in 3 min (B=90% acetonitrile, 0.5% acetic acid). A flow rate of 
ca. 200 nL/min was used to elute peptides from the RP nano-column to an emitter nanospray 
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needle for real time ionization and peptide fragmentation on a Q-Exactive mass spectrometer 
(Thermo Fisher). An enhanced FT-resolution spectrum (resolution=70000) followed by the 
MS/MS spectra from most intense fifteen parent ions were analyzed along the chromatographic 
run (272 min). Dynamic exclusion was set at 30 s. For protein identification, tandem mass 
spectra were extracted and charge state deconvoluted by Proteome Discoverer 1.4.0.288 
(Thermo Fisher). All MS/MS samples were analyzed using SEQUESTTM (Thermo Fisher) with 
a fragment ion mass tolerance of 20 PPM and a parent ion tolerance of 15 PPM. 
Carbamidomethyl of cysteine was specified in Sequest as a fixed modification. Oxidation of 
methionine was specified in Sequest as a variable modification. Peptide quantification from 
FullScan spectra and labelling efficiency calculation were performed as described using 
QuiXoT, a custom software written in C#. Statistical analysis was done as reported46. The 
standardized variable Zq describes the log2 ratio for each protein corrected for the 
corresponding systematic error, in each experiment. Finally, data were plotted using R (v3.6.1). 
The code will be provided upon request. Statistical data on all proteomics analysis are 
presented in Supplementary Table 8. 
Proteomic analysis of neutrophils by tandem mass tag (TMT) 
For proteomic analysis of human neutrophils, two million isolated cells were pelleted in 1.5ml 
Eppendorf Tubes and snap-frozen at -80ºC. Upon analysis of purity, the best 5 samples (96 % 
mean purity) were used for multiplexed proteomic analysis at 8 am and 2 pm. For mouse 
neutrophils, one hundred thousand cells were sorted from Bmal1∆N mice at ZT5 or ZT13 (see 
cell sorting section below). 
Total protein extracts from each sample were treated with 50 mM iodoacetamide (IAM) and 
digested overnight at 37°C with trypsin (Promega, Madison, WI, USA) at a 40:1 protein:trypsin 
(w/w) ratio using the Filter Aided Sample Preparation (FASP) digestion kit (Expedeon) 
according to manufacturer’s instructions. The resulting peptides were desalted with C18 Oasis 
cartridges (Waters Corporation, Milford, MA, USA), using 50% acetonitrile (ACN) (v/v) in 0.1% 
trifluoroacetic acid (v/v) as eluent, and vacuum-dried. The peptides were TMT-labeled following 
manufacturer’s instructions, desalted, separated into 4 fractions using the high pH reversed-
phase peptide fractionation kit (Thermo Fisher) and analyzed using a Proxeon Easy nano-flow 
HPLC system (Thermo Fisher, Bremen, Germany) coupled via a nanoelectrospray ion source 
(Thermo Fisher) to a Q Exactive HF Orbitrap mass spectrometer (Thermo Fisher). C18-based 
reverse phase separation was used with a 2-cm trap column and a 50-cm analytical column 
(EASY column, Thermo Fisher) in a continuous acetonitrile gradient consisting of 0-30% A for 
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240 min, 50-90% B for 3 min (A= 0.1% formic acid; B= 90% acetonitrile, 0.1% formic acid) at a 
flow rate of 200 nL/min. Mass spectra were acquired in a data-dependent manner, with an 
automatic switch between MS and MS/MS using a top 15 method. MS spectra in the Orbitrap 
analyzer were in a mass range of 400–1500 m/z and 120,000 resolution. HCD fragmentation 
was performed at 28 eV of normalized collision energy and MS/MS spectra were analyzed at 
30,000 resolution in the Orbitrap. 
All database searches were performed with Proteome Discoverer (version 2.1, Thermo Fisher) 
using SEQUEST-HT (Thermo Fisher) against a Uniprot database containing all sequences from 
Human (July, 2018; 20,408 entries). For database searching, parameters were selected as 
follows: trypsin digestion with 2 maximum missed cleavage sites, precursor mass tolerance of 2 
Da, fragment mass tolerance of 30 ppm. Methionine oxidation (+15.994915) was set as a 
variable modification. Lysine and peptide N-terminal modification of + 229.162932 Da, as well 
as cysteine carbamidomethylation of +57.021464 Da, were set as fixed modifications. The same 
MS/MS spectra collections were also searched against inverted databases constructed from the 
same target databases. Peptide identification from MS/MS data was performed using the 
probability ratio method. False discovery rates (FDR) of peptide identifications were calculated 
using the refined method. A 1% FDR was used as the peptide identification criterion. Each 
peptide was assigned only to the best protein proposed by the Proteome Discoverer algorithm. 
Quantitative information from TMT reporter intensities was integrated from the spectrum level to 
the peptide level, and then to the protein level based on the WSPP model58 using the Generic 
Integration Algorithm (GIA)59,60. Briefly, for the human experiment, for each sample , the values 
	log /  were calculated, where  is the intensity of the TMT reporter of the 2pm 
sample from the individual  in the MS/MS spectrum  coming from peptide  and protein , and 
 is the intensity of the TMT reporter from the 8am sample from the same individual. Protein 
quantifications where further integrated among the 5 comparisons in the human experiment, 
obtaining for every protein averaged value ( ′) with their corresponding weights ( ′ 60.  
In the mouse TMT experiments, for each sample i, the values xqps= log2Ai/Ci were calculated, 
where Ai is the intensity of the TMT reporter from the individual i in the MS/MS 
spectrum s coming from peptide p and protein q, and Ci is the averaged intensity of the TMT 
reporters from all the samples in the given TMT experiment. The log2-ratio of each peptide ( ) 
was calculated as the weighted mean of its spectra, the protein values ( ) were the weighted 
mean of its peptides, and the grand mean ( ̅) was calculated as the weighted mean of all the 
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protein values58. The statistical weights of spectra, peptides, and proteins ( ,  and , 
respectively) and the variances at each one of the three levels ( , , and , respectively), 
were calculated as described 58. Protein quantifications where further integrated among the 
corresponding replicates from the same condition, obtaining for every protein averaged values 
( ′) with their corresponding weights ( ′  58.  
In all cases, protein abundance changes were then expressed in standardized units (Zq), from 
which statistical significance of the changes in terms of the p-value were calculated. P-values 
were corrected for multiple hypothesis testing by controlling for the False Discovery Rate (FDR). 
Significant abundance changes of proteins in the compared samples were considered 
significant at 1% FDR. 
Data were analyzed using R (v3.6.1). The analysis code will be provided upon request. 
Statistical data on all proteomics analysis is presented in Supplementary Table 8. 
Proteomics-transcriptomics correlations 
To analyze the correlation between proteomics and transcriptomics data of fresh and aged 
neutrophils, we compared our proteomics data with previously-generated RNA sequencing data 
on fresh (sorted at ZT13 from blood) and aged neutrophils (sorted at ZT5 from blood) available 
in GEO: GSE86619 12. To this end we obtained a set of common proteins and genes from both 
datasets, compared the proteomics Z-score and the sequencing Log2FC (both inform about the 
relative enrichment in fresh neutrophils) and calculated the regression (Spearman) statistics 
using R (v3.6.1). We performed similar analyses for paired transcriptome and proteome data 
from human samples. 
Cytometry and cell sorting 
Cytometric analyses were performed using a Sony SP6800 Spectral Analyzer (Sony 
Biotechnology, Japan). Analysis was performed using Flowjo vX (Tree Star Inc, Ashland, OR). 
Cell sorting experiments were performed using an FACS Aria cell sorter (BD Biosciences). All 
analyses were conducted at the Cellomics Unit of the CNIC. The following antibodies and 
streptavidin conjugates were used in this study: 
Antibody /  Clone Species Manufacturer 
CD16-APC 3G8 Human BD 
CD62L-FITC DREG56 Human BD 
CD11b-PE M1/70 Human/Mouse Tonbo biosciences 
Ly6G-AF647 1A8 Mouse eBioscience 
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CD45-APC/Cy7 104 Mouse Biolegend 
CXCR2-PerCP-Cy5.5 SA044G4 Mouse Biolegend 
CXCR4-PE 2B11 Mouse eBioscience 
CD41-PE MWReg30 Mouse eBioscience 
CD62L-FITC MEL-14 Mouse eBioscience 
CD11b-BV510 M1/70 Mouse Biolegend 
CD31-APC 390 Mouse eBioscience 
CD31 2H8 Human/Mouse Thermo Fisher 
MPO-biotin Polyclonal Human/Mouse R&D (biotinylated in-house) 
citH3 (R2+R8+R17) Polyclonal Human/Mouse Abcam 
Goat-anti-hamster-AF405 Polyclonal Hamster Jackson ImmunoResearch 
Goat-anti-rabbit-AF647 Polyclonal Rabbit Thermo Fisher 
Streptavidin-AF488 N/A Mouse/Human/Rat BioLegend 
	
In vivo NET formation during ischemia/reperfusion 
The cremaster muscle was exteriorized as reported 12, and ischemia was achieved by occlusion 
of the inflowing and outflowing vessels by clamping the tissue connecting the muscle and the 
animal’s body with a 15mm Micro Serrefine clamp (Fine Science Tools, Heidelberg, Germany) 
for 45 min. Reperfusion was achieved by removal of the clamp. 15 min after reperfusion, mice 
were euthanized and cremaster muscle removed for analysis. Excised muscles were fixed in 
4% paraformaldehyde at 4ºC overnight and then washed 3 times in PBS containing 0.5% Triton-
x 100 (PBST) and blocked for 2 h in PBST 25% FBS at room temperature with shaking. Staining 
was performed using anti citrunillated-H3, anti-MPO and anti-CD31 antibodies in 10% FBS-
PBST overnight at 4ºC with shaking. Then, secondary antibodies were stained in 10%FBS-
PBST for 4h at room temperature. Samples were then washed and mounted in Mowiol 4-88 
(Mw 31,000; Sigma). Imaging of whole-mount cremaster muscles was performed using a Nikon 
A1R confocal system coupled to a Nikon Eclipse-Ti inverted microscope with the following lines: 
Diode 402nm Argon Laser 457, 476, 488, 514nm Diode 561nm HeNe Laser 642nm using a 
Plan Apo 10x/0,45 dry objective and the software NIS Elements AR 4.30.02 (Build 1053 LO, 64 
bits, Nikon Instruments, Tokyo, Japan), and were afterwards analyzed using Imaris (Bitplane 
AG, Zurich, Switzerland). All imaging was performed at the Microscopy & Dynamic Imaging Unit 
of CNIC. 
Quantification of primary granules 
Blood samples were extracted every 4 h during 24 h from wild-type mice, starting at ZT1. 100 
microliters of blood were RBC-lysed in hypotonic lysis buffer (0.15M KH4Cl, 0.01M KHCO3 and 
0.01M EDTA in water), washed with PBS and resuspended in 40 microliters of PBS. Smears 
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were then performed onto Superfrost Plus microscope slides (Thermo Scientific, Waltham, 
USA), air-flow dried and immediately fixed in 4% PFA for 10 min at room temperature. For the 
experiments with mutant mice, neutrophils were sorted as described, cytospun (600 RPM, 
medium acceleration) into microscope slides and fixed with PFA 4% for 10 min at room 
temperature. For CXCL2 stimulation experiments, sorted neutrophils were plated with RPMI 
medium on Poly-L-lysine covered 8-well μ-Slides (Ibidi, Martinsried, Germany) and left 30 min to 
adhere. Cells were then incubated for 1h with 50ng/ml of recombinant CXCL2 (R&D Systems) 
or vehicle, and fixed with 4% PFA in PBS.  
For neutrophils in blood vs tissues, we sorted cells and cytospun them as described. Prior to 
sorting, the tissues were extracted and kept in cold PBS (except liver, kept at room temperature 
in HBSS) and processed immediately after. To avoid activation of neutrophils, we did not 
perform digestion of the tissues, but mechanically dissociated them into single-cell suspensions 
by straining in 100μm pore cell strainers (Falcon). Enrichment of leukocytes from liver was 
performed by 36% Percoll (GE Healthcare) in HBSS (Invitrogen) gradient centrifugation.	Single-
cell suspensions were incubated with antibodies against CD45, CD11b and Ly6G prior to 
sorting of CD45+, CD11b+, Ly6G+ neutrophils. Finally, cytospun neutrophils were fixed as 
described above. 
For the light cycle inversion experiments, WT mice were housed in light cabinets with inverted 
light cycle for three weeks prior to blood withdrawal for analysis. Then, whole blood extracted in 
EDTA tubes was RBC-lysed and smears were performed as described above. 
In all cases, after washing, cells were permeabilized for 30 min with 0.1% Triton, 25% FBS in 
PBS and stained with biotinylated anti-MPO antibody at 4ºC overnight. Afterwards, cells were 
washed and incubated with A488-conjugated Streptavidin for 3h at room temperature. Finally, 
cells were washed, stained with DAPI and mounted in Mowiol. Imaging was performed using a 
Leica SP8 X confocal microscopy system coupled to a DMI6000 inverted microscope, with 100x 
(HC PL Apo CS2 100x/1.4 OIL) magnification objective. Granule contents were analyzed using 
the Imaris software. 
Ex vivo NET-formation assays 
Neutrophils were sorted as previously described and 5x104 neutrophils were plated with RPMI 
medium on Poly-L-lysine covered 8-well μ-Slides (Ibidi, Martinsried, Germany), and left 30 min 
to adhere. Subsequently, cells were incubated for 2h with 100nM PMA or vehicle. Cells were 
then fixed using PFA 4% for 10 min, permeabilized with PBS 0.1% Triton X-100 1% goat serum 
27 
 
plus 5% BSA and stained with antibodies against citrullinated histone 3, DNA (Sytox green, 
Molecular Probes) and MPO. Whole-slide z-stack tilescan images were acquired with a Nikon 
A1R confocal system coupled to a Nikon Eclipse-Ti inverted microscope or a Leica SP5 
confocal microscope and analysed using Imaris. 
Antibody-induced acute lung injury (ALI) 
A two-event model of transfusion-related ALI was adopted for our studies as described 15. Male 
Balb/c mice (7-14 week-old) were injected intraperitoneally with 0.1 mg/kg LPS. 24 hours later, 
mice received an intravenous injection of 0.5 mg/kg anti-H2d (clone 34-1-2s; BioXcell) antibody. 
Some mice were treated 1h before ALI induction with 12mg/kg of Cl-Amidine (Cayman 
Chemical Company, Ann Arbor, Michigan, USA) to block NET-formation (31). For survival 
experiments, mice were observed for 2h during the acute phase of ALI. 
Neutrophil elastase activity assay 
NE activity in plasma was measured using a commercially available kit (Neutrophil Elastase 
activity assay kit - Fluorometric, NAK246-1KT, Sigma-Aldrich) according to the manufacturer’s 
instructions. We analyzed 50 microliters of plasma, with an excitation wavelength of 390nm and 
emission wavelength of 510nm in a Fluoroskan Ascent plate reader (Thermo Labsystems). 
Standard curve goodness of fit had an R-square of 0.99 in linear regression. 
Intravital imaging of the lung 
Intravital microscopy of the lung was performed as reported 28. Briefly, mice were anesthetized 
and mechanically ventilated through the trachea using a small animal ventilator model 687 
(Harvard Apparatus). Then, right lateral thoracotomy was applied, and the lung was positioned 
under the window of a custom-built fixation device. A mil vacuum was applied to hold the lung in 
position during microscopy. Mice were injected with AF647-conjugated Ly6G antibody to stain 
neutrophils, PE-conjugated CD41 antibody to stain platelets and Sytox green (Molecular 
Probes) to stain extracellular DNA. 4D imaging was performed for each mouse in 5 random 
fields inside the visualization window, using the VIVO system12. Analysis was performed in 
Imaris software. For NET-like structures, we quantified the number of spots in the neutrophil-
extracellular DNA colocalization channel over time in all random fields. 
Analysis of NET types in lungs 
We found two types of NET-formation events in lungs during ALI. Flowing NETs were defined 
as events in which DNA was rapidly extruded out of the neutrophil and most commonly was 
washed away by the flow; and adherent NETs, which were defined as DNA being deployed 
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slowly around the uropod region of the neutrophil as it crawled, stuck to the vasculature and 
was more resistant to blood-flow washing. To quantify the relative frequency of each of them, 
we visually inspected every NET formation event in our time-lapse footage and ascribed each 
event to one of the two categories, or none if it was unclear. 
Whole mount immunostaining and tissue clearing 
To confirm the presence and abundance of NETs in the lungs of mice upon ALI induction we 
performed whole mount immunostaining and tissue clearing of excised lungs. Mice were subject 
to ALI and euthanized with CO2 15 min after ALI induction. Mice were then perfused with 20ml 
of saline through the left ventricle of the heart, and the lungs were collected in cold PBS. 
Afterwards, lungs were fixed at 4ºC overnight in PBS with 4% PFA and 30% sucrose. After 3 
washes of 1h with PBS at room temperature, tissues were permeabilized in methanol gradients 
in PBS for 30 min (PBS > MetOH 50% > MetOH 80% > MetOH 100%). Then, tissues were 
bleached with Dent’s bleach (15% H2O2, 16.7% DMSO in MetOH) for 1h at room temperature, 
and then were rehydrated through descending methanol gradients in PBS (MetOH 80% > 
MetOH 50% > PBS). Then tissues were incubated with blocking buffer containing PBS with 
0.3% Triton X100, 0.2% BSA, 5% DMSO, 0.1% azide and 25% FBS overnight at 4ºC with 
shaking. Afterwards lungs were stained with antibodies against citrunillated histone 3, MPO and 
CD31 for 2 days at 4ºC with shaking. After washing for 24h in washing buffer (PBS with 0.2% 
Triton X100 and 3% NaCl), the tissues were stained with secondary antibodies anti-rabbit 
AF647, antiHamster-AF405 and Streptavidin AF488 for 24h at 4ºC with shaking. 24h later, 
tissues were washed for 24h in washing buffer and were dehydrated in MetOH gradients in 
dH20 using glass containers for 30 min in each step (MetOH 50% > MetOH 70% > MetOH 90% 
> 3x MetOH 100%). Finally, tissues were cleared for 30 min in MetOH with 50% BABB and 
afterwards in 100% BABB (benzyl alcohol, benzyl benzoate 1:2) and imaged in a Leica SP8 X 
confocal microscopy system coupled to a DMI6000 inverted microscope. 
Computerized tomography (CT) for in vivo edema quantification  
In vivo CT imaging was performed on a nanoPET/CT small-animal imaging system (Bioscan, 
Washington DC) equipped with a micro-focus X-ray source and a high-resolution detector 
(1024x3596 pixels; 48 μm pixel size). Acquisition parameters were 55 kVp and 73 µAs. Mice 
were intraperitoneally anesthetized and positioned onto a thermoregulated (30 degrees) mouse 
bed until the scan was completed. An ophthalmic gel was administered in their eyes to prevent 
retinal drying. Six studies were acquired per animal: one prior the retro-orbital injection of anti-
H2d to induce ALI, and five post-injection during 30 min approximately. Data were acquired in 
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helical mode obtaining 240 projections per rotation with 768 μm pixel size. Reconstruction was 
performed with an FDK-based method included in the proprietary Nucline software (Mediso, 
Budapest, Hungary). Pulmonary edema was quantified using Horos software (The Horos 
Project, distributed under the LGPL license at Horosproject.org and sponsored by Nimble Co 
LLC d/b/a Purview in Annapolis, MD, USA) as the change of the mean value, in Hounsfield 
Units, within the region of interest of the lungs obtained by thresholding (-1000 and -400 lower 
and upper thresholds, respectively) followed by a closing morphological operation. 
Intravital imaging of the cremaster muscle to quantify platelet-neutrophil interactions 
Intravital microscopy of the cremaster muscle after TNFα stimulation (R&D Systems, 0.5μg 
intrascrotal injection) was performed as previously reported 12, 15 using the VIVO system. Ten to 
twenty venules segments per mouse were analyzed 150 to 210 min after TNF-α treatment in 
multiple fluorescence channels (Cy3/561 for PE, FITC/488 for FITC and Cy5/640 for APC) and 
bright-field images with 1x1 or 2×2 binning with 3 second interval for 2 min on each field of view. 
For double staining with PE- and FITC-conjugated antibodies, acquisition was facilitated in 
single (FITC) and quadrant (PE) filters in order to avoid bleed-through of fluorescent signals 
between channels. For the visualization of leukocytes, fluorescently labelled anti-Ly6G-APC and 
anti-CD62L-FITC antibodies were injected, and to visualize platelets, anti-CD41-PE was 
injected intravenously at 1 μg/mouse. Quantification of neutrophil-platelet interactions in either 
the leading edge or trailing edge was performed using Slidebook (3I). 
Circadian analysis of neutrophil phenotypes 
Circadian blood samples were extracted every 4 h during 24 h from wild-type or experimental 
mice, starting at ZT1 (Zeitgeber time, 1 hour after the onset of light, 7:00 at the CNIC’s animal 
facility). For circadian surface marker analysis, blood counts were analyzed in an automated 
hemocytometer (Abacus Junior, Diatron; Holliston, USA), RBC were lysed in hypotonic lysis 
buffer (0.15M KH4Cl, 0.01M KHCO3 and 0.01M EDTA in water) and incubated 15 min with 0.25 
μg anti-Ly6G, -CD62L and -CXCR2 antibodies, washed and analysed in a Sony SP6800 
Spectral Analyzer. Analysis was performed using Flowjo vX (Tree Star Inc, Ashland, OR). 
Vascular permeability assay 
A 0.5% solution of Evans blue in sterile PBS was prepared and 200μl of the solution was i.v. 
injected into mice 15 min before TRALI induction (or just LPS injection as control, see protocol 
for ALI). 15 min later mice were sacrificed, and tissues extracted and weighted. Then, tissues 
were submerged in 0.5 ml formamide and incubated at 55ºC for 24h. Tissues were removed, 
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and the tubes centrifuged for 5 min at 645 g. Finally, supernatants were measured for 
absorbance at 610nm using an xMark Microplate Spectrophotometer (BioRad) plate reader. 
Human studies 
We performed human proteomics, RNA sequencing, NET-formation assays and granule 
quantification (see individual methods) in neutrophils from blood samples of heathy volunteers 
obtained at 8am, 2pm and 7pm at Hospital 12 de Octubre. The study complied with all ethical 
regulations and was approved by the Ethical Research Committee of Hospital 12 de Octubre in 
Madrid (CEIm #18/389), and informed consent was obtained from all volunteers. 
Human neutrophil granule quantification 
Diurnal blood samples were extracted from healthy volunteers at 8am, 2pm and 7pm. One 
hundred microliters of blood were processed as imaged as indicated above for mouse 
neutrophils. 	
Human neutrophil isolation 
12 ml of freshly obtained blood extracted from healthy volunteers at the indicated times were 
used to isolate human neutrophils using Histopaque 1119 and 1077 (Sigma) gradients. In a 
50ml falcon tube 15ml of Histopaque 1119 were added and then 15 ml of Histopaque 1077 were 
carefully layered on top. Whole blood was carefully layered on top of the low-density solution, 
and tubes were centrifuged for 30 min at 340g at room temperature, with no brakes or 
acceleration. Neutrophils layering between the 1077 and 1119 interphase were carefully 
aspirated and the isolated neutrophils washed twice in PBS. We obtained over 95% purity as 
assessed by flow cytometry. 
RNA sequencing of human neutrophils 
Total RNA was prepared with the RNA Extraction RNeasy Plus Mini-kit (QIAGEN). 1 ng of total 
RNA were used to generate barcoded RNA-seq libraries as previously described12. 
Libraries were sequenced on a HiSeq2500 (Illumina) to generate 60 bases single reads. FastQ 
files for each sample were obtained using bcl2fastq 2.20 Software software (Illumina). The RNA 
sequencing experiments were performed at the Genomics Unit at CNIC. 
Human ex vivo NET formation assay 
4x104 Human neutrophils isolated as previously described were plated with RPMI medium on 
Poly-L-lysine covered 8-well μ-Slides (Ibidi, Martinsried, Germany) and left 30 min to adhere. 
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Adherent cells were incubated for 2h with 250ng/ml PMA or vehicle and then fixed using PFA 
4% for 10 min, permeabilized with PBS 0.1% Triton X-100 1% goat serum plus 5% BSA and 
stained with antibodies against citrullinated histone 3 (Abcam, Cambridge, UK), DNA (Sytox 
green, Molecular Probes) and MPO (R&D Systems). Whole-slide z-stack tilescan images were 
acquired with a Leica SP5 confocal microscope. Analysis of extra-nuclear DNA was performed 
using ImageJ with an automated method for extranuclear DNA quantification made available 
in https://doi.org/10.6084/m9.figshare.7358642.v1 
Retrospective analysis of human ARDS  
Data from acute respiratory distress syndrome (ARDS) was extracted from a prospective 
observational cohort study of 5334 consecutive adult patients with community-acquired 
pneumonia admitted to the ICU that developed ARDS between 1996 and 2016 32, in Hospital 
Clinic of Barcelona, Spain. The time of admission, severity and survival was determined for the 
125 patients that developed ARDS. Patients were excluded if they had severe 
immunosuppression or active tuberculosis. ARDS was identified based on the Berlin definition. 
Only time points with 3 or more data points were included in subsequent analysis. The study 
was approved by the ethics committee of Hospital Clinic of Barcelona (no. 2009/5451).  
Transmission electron microscopy imaging of neutrophils 
Neutrophils from mouse and human blood were isolated as previously described (FACS sorting 
for mouse neutrophils, gradient isolation for human neutrophils), fixed in 4% PFA for 10 min and 
washed with PBS. Samples were then post-fixed in distilled water containing 4% of osmium 
tetroxide for 1h at room temperature. After washing in distilled water, samples were stained in a 
block with uranyl acetate 0.5% in water for 10 min. Then, samples were dehydrated in 
ascending gradients of ethanol in water (30%, 50%, 70%, 95% and 100%) with a last step in 
acetone. Samples were then included in epoxi resin (Durcupan) in ascending steps of 
resin:acetone (1:3, 3:1) and then pure resin. Samples included in the resin were polymerized for 
48h at 60ºC and 60nm slices were obtained in a Leica Ultracut S ultramicrotome in 200 mesh 
Cu gratings. Finally, samples were counterstained with uranyl acetate and lead citrate. Images 
were acquired in a 100Kv Jeol JEM1010 TEM microscope (Tokyo) with a Gatan SC200 
(Pleasanton CA) camera coupled to the system. Quantification of granule-covered cytoplasmic 
area was performed in ImageJ using a custom-made macro that allows calculation of cell, 
nucleus and granule areas, made available in: https://doi.org/10.6084/m9.figshare.7619093.v1 
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Code availability  
ImageJ macros for TEM granule quantification and extracellular DNA quantification are 
available in FigShare (see the relevant method for specific links). All other pieces of code are 
available upon request.  
Statistical analysis 
Unless otherwise indicated, data are represented as mean values ± standard error of the mean 
(SEM). Paired or unpaired two-tailed t-test was used when 2 groups were compared, and 
comparison of more than two data sets was done using one-way analysis of variance (ANOVA) 
with Turkey’s post-test. Where applicable, normality was estimated using D’Agostino & Pearson 
or Shapiro-Wilk normality test. Log-rank analysis was used for Kaplan-Meier survival curves. 
Sample exclusion was not performed unless evident signs of disease were found in a mouse. 
For determination of diurnal patterns, we performed COSINOR fitting of circadian curves 12. To 
determine whether a diurnal curve displayed an oscillating pattern we used the COSINOR-
calculated amplitudes and compared them with a hypothetical zero-amplitude curve (i.e. with no 
circadian behavior) assuming that both curves have identical standard deviations. We finally 
compared the two curves’ amplitudes using unpaired two-tailed t-test analyses. All statistical 
analyses were performed using Prism v7 (GraphPad Software, California, USA), except 
proteomics and sequencing analysis, which were performed using R (see individual methods). A 
p-value below 0.05 was considered statistically significant; non-significant differences (n.s.) are 
indicated accordingly. 
Data availability 
Proteomics data for mouse and human neutrophils are available in the Peptide Atlas with 
accession number: PASS01364. Proteomics data for Bmal1∆N mice at ZT5 and ZT13 and WT 
vehicle vs AMD-3100 treated mice are also available in the Peptide Atlas with the accession 
number: PASS01438. Mouse circadian transcriptomics used for the correlation analysis are 
available at the Gene Expression Omnibus with accession number GSE102310. Human 
sequencing data used for the correlation analysis are available at GEO with accession number: 
GSE136632. All other pieces of data are available upon request. 
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Figures and Figure legends 
 
Figure 1. Diurnal changes in the neutrophil proteome. 
(A) Experimental strategy for proteomic analysis of aged and fresh neutrophils. (B) Volcano plot 
of proteins with a False Discovery Rate (FDR) < 0.01. A positive Z-score represents an increase 
in nighttime (fresh) over daytime (aged) neutrophils. Color represents the functional category for 
each protein (legend, top-right). (C) Gene-set enrichment analysis of the proteomics data showing 
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pathways with a p-value < 0.15 enriched in aged (red) or fresh (blue) neutrophils. Size of the 
bubble-plot represents overlap between query and gene-set (legend bottom-right). (D) Volcano 
plot of the proteomic dataset showing granule proteins with a Z-score > 2. Colors show the granule 
type for each protein. (E) Z-stack maximum projection of neutrophils stained for primary granules 
with MPO and counterstained with DAPI. (F) Quantification of neutrophil granule contents during 
a full diurnal cycle. Curves are repeated (dashed line) to better appreciate the circadian pattern. 
Dark phase is shown in grey; n=30 cells per time point. G) Neutrophil elastase activity in plasma. 
Curves are repeated (dashed line) to better appreciate the circadian pattern. Dark phase is shown 
in grey; n=4 mice per time point. Data in (F, G) are shown as mean ± SEM, and p-values were 






Figure 2. Diurnal loss of NET-forming capacity. 
(A) Volcano plot of the neutrophil proteome showing proteins found in NETs (red dots), and 
enrichment of these proteins in nighttime neutrophils. (B) Ex vivo NET-formation assay. 
Neutrophils sorted at ZT13 (nighttime) or ZT5 (daytime) were stimulated with PMA or vehicle to 
induce NETs and stained for citrunillated-histone 3 (Cit-H3) and DNA (top). Colocalization of both 
markers was used to quantify NET formation as shown in the bar graph (bottom); n=3 mice per 
time point. (C) Representative images (left) and quantification (right) of in vivo NET formation in 
the cremaster muscle subjected to ischemia/reperfusion at nighttime (ZT13), or at daytime (ZT5). 
Triple colocalization of MPO, DNA and Cit-H3 was used to define and quantify the area of NETs 
(red; arrowheads). Neutropenic Mcl1∆N mice (Lyz2Cre; Mcl1fl/fl mice) were used as controls and 
showed no NETs. Dotted areas are showed magnified in bottom panels; n = 3 mice per condition. 
Scale bars, 50 m. Bars show mean ± SEM. *; p<0.05; n.s., not significant, as determined by 





Figure 3. Degranulation and loss of NET-forming capacity are driven by CXCL2/CXCR2 
signaling.  
(A) Ex-vivo stimulation of sorted neutrophils with CXCL2 induces degranulation (right), as 
quantified by confocal imaging of MPO-stained neutrophils (left); n = 29-32 cells. (B) Diurnal 
quantification of granule content in neutrophils from WT, CXCR2∆N or CXCL2 mice, showing a 
loss of diurnal fluctuation in CXCR2-defici 
ent (n = 38-40 cells) or CXCL2-deficient neutrophils (n = 15-31), compared to their WT 
counterparts (n = 30-33 cells per time point). (C) Ex-vivo NET formation assays with sorted 
neutrophils stimulated with PMA or vehicle control, at nighttime (ZT13) or daytime (ZT5). NETs 
were quantified by triple-colocalization of citrunillated-histone 3, DNA and MPO in confocal 
micrographs (left). Each mouse was normalized to its vehicle control and NET formation at ZT13 
and ZT5 compared (right). CXCL2-deficient (n = 3 mice per time) and CXCR2-deficient (n = 2-6 
mice per time) neutrophils showed loss of diurnal fluctuation in NET formation compared with WT 
cells (n = 4-6 mice per time). (D) CXCL2 signaling causes degranulation cell-autonomously, as 
shown by analysis of MPO+ granules in neutrophils from BM chimeras reconstituted with DsRed+ 
wild-type and DsRedNEG Cxcl2 donors; n = 3 mice. Bars show mean ± SEM. **; p<0.01; n.s., 




Figure 4. Diurnal loss of NET formation and pulmonary protection during ALI.  
(A) Presence of NETs in lungs. Shown are maximum projections of confocal Z-stack series of 
cleared lungs from control mice (Basal) or mice with antibody-induced acute lung injury induction 
(ALI). Lungs were stained against citrunillated-histone 3, MPO and DNA, and some NETs are 
shown (arrowheads). (B) Time-series of 4D intravital imaging captures of NET-like structures in 
the lungs of ALI-induced mice. NET-like structures were defined as free DNA extruded out of 
Ly6G+ neutrophils. See also Movie S1. (C) Quantification of NET-like structures as shown in (B), 
and normalized to the number of neutrophils in mice in which ALI was performed at nighttime 
(ZT13) or daytime (ZT5), or in mice treated with Cl-amidine (at ZT5). Time course (left panel) and 
area under the curve values (right panel); n = 15 fields from 4 mice per condition. (D) 
Representative images of longitudinal CT series of edema formation at 0 or 21 min after inducing 
ALI ZT13 or ZT5. Note the increased edema (red) at night. Background bone signal (grey) is 
shown for anatomical positioning. (E) Quantification of the images in (D). Volume of edema was 
increased at ZT13 (blue; n = 7) relative to ZT5 (red; n = 7). Mice treated with Cl-amidine are shown 
as a control (grey, n = 4). (F) Survival of mice subjected to ALI at ZT13 (blue) or ZT5 (red), or 
treated with Cl-amidine (gray); n = 11-21 mice. Data are shown as mean ± SEM. **; p<0.01; ***, 
p<0.001, as determined by one-way ANOVA with Dunnet’s multiple comparison test (C), two-way 




Figure 5. Diurnal degranulation and pulmonary protection is neutrophil-intrinsic. 
(A) Confocal micrographs and quantification of primary granules in neutrophils from WT mice at 
night (ZT13) or daytime (ZT5), and from mutant mice (both at ZT5); n = 30-50 cells from 3 mice. 
(B) Transmission electron microscopy images (left), and quantification of electrodense azurophilic 
granules (right) in WT and mutant mice (all at ZT5), showing increased granule content in 
Bmal1∆N, and reduced in CXCR4∆N neutrophils compared with WT cells; n = 19. (C) Ex vivo NET 
formation in sorted WT, Bmal1∆N or CXCR4∆N neutrophils stimulated with PMA or vehicle as 
control; n = 3 per condition. (D) Quantification of NET-like structures normalized to the number of 
27 
 
neutrophils during ALI in Bmal1∆N or CXCR4∆N mice. Time course and elevations from baseline 
(gray area) are shown in the left panel, and the areas under the curve are shown in the right panel. 
Experiments were performed at ZT5. Data from wild-type mice at ZT5 and ZT13 (from Figure 4C) 
are shown for reference; n = 15 fields from 3 mice per condition. (E) Representative images of 
longitudinal CT series of edema (red) in mutant mice subject to ALI (left), and quantification of the 
edema volume over time (right panel); n = 7 mice per genotype. (F) Survival curves of Bmal1∆N 
and CXCR4∆N mice subjected to ALI; n = 12-19 mice per genotype. Data are shown as mean ± 
SEM. *; p<0.05; **, p<0.01; ***, p<0.001; n.s., not significant, as determined by one-way ANOVA 







Figure 6. Evidence for neutrophil disarming and pulmonary protection in humans.  
(A) Experimental design. Blood from 10 healthy volunteers was extracted at 8 am, 2pm and 7 pm. 
Neutrophils were purified for proteomic analysis, granule quantification and NET-formation 
assays. (B) Blood neutrophil counts in human volunteers at the different time points; n = 10. (C) 
Light scattering (SSC-A) values for human neutrophils at different times, as measured by flow 
cytometry; n = 10 human volunteers. (D) Quantification of primary granules from confocal images 
of human neutrophils from images in (E); n = 150 cells from 10 volunteers. (E) Representative 
images of granule content of human neutrophils. (F) Transmission electron micrographs (left) of 
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human neutrophils in the morning (8 am) and early afternoon (2 pm) showing reduced numbers 
of electrodense primary granules (right); n = 33 cells from 3 human volunteers. (G) Volcano plot 
of granule proteins in the human neutrophil proteome, showing higher content in granule proteins 
(color-coded) at 8 am compared with 2 pm; n = 5 samples from healthy volunteers. Red dots and 
labels show differentially expressed proteins with p-value<0.05, and black dots show all granule 
proteins. Label color indicates the granule type in which the protein is normally found (bottom 
right). (H) Quantification of ex vivo NET formation by human neutrophils stimulated with PMA or 
vehicle at the indicated time points. Representative confocal images of the PMA-induced NETs 
are shown in (I); n = 10 volunteers. (J) Acute respiratory distress syndrome (ARDS) severity 
shown as the pneumonia severity index (left) and intra-hospitalary deaths (right), of patients 
entering the ICU at different times of the day; n = 125 patients. Data are shown as mean ± SEM. 
**; p<0.01, as determined by unpaired t-test analysis (F). P values for the circadian plots were 
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Extended Data Figure 1. Validation and analysis of neutrophil proteomics.  
a, Experimental strategy for proteomic analysis of day-like (from P- and E-selectin treated mice) 
and night-like (from AMD3100-treated mice) neutrophils isolated by negative selection (see 
methods) from blood. b, Intracellular staining of proteins from the proteomics dataset for validation 
in fresh (blue) and aged (violet) neutrophils obtained as indicated in a. All the proteins analyzed 
correlated with the proteomics data; n=3 mice per condition. c, GO terms of the differentially 
expressed proteins (FDR < 0.05, see methods section for 18O proteomics) in the proteomics 
dataset, showing terms with p < 0.05 (from single samples of 60 million neutrophils pooled from 
9 mice (night) and 6 mice (day)). Bubble size represents overlap of query vs. the GO term. d, 
Scatterplot, correlation coefficient and significance level (pvalue) of the Spearman’s correlation of 
the direction of change of common proteins and genes from our proteomic analysis of fresh and 
aged neutrophils (this paper) and circadian RNA-sequencing data previously reported (Adrover 
et al. 2019, from 3 mice at ZT5 and 3 mice at ZT13), showing poor correlation of RNA and protein 
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content. e, Venn-diagram showing the number of differentially detected proteins (p<0.05, see 
methods section for mouse TMT proteomics) between vehicle- and AMD3100-treated mice (at 
ZT5); n=3 samples per group. f, Heatmap showing levels of granule proteins in this dataset, Note 
increased detection of most granule proteins in neutrophils from AMD3100-treated mice. Data in 
(b) are shown as mean ± SEM. *; p<0.05; **, p<0.01; ***, p<0.001, as determined by unpaired 




Extended Data Figure 2. Degranulation of neutrophils in the circulation and in tissues.  
a, Reactome pathway analysis of the proteome of night and day neutrophils (see methods section 
for 18O proteomics, from single samples of 60 million neutrophils pooled from 9 mice (night) and 
6 mice (day)) showing pathways with p-value < 0.05. b, Light scattering properties (a measure of 
granularity) of blood neutrophils during a full diurnal cycle, measured as side-scatter in flow 
cytometry. Data are for WT, CXCR2-, CXCR4- or Bmal1-deficient neutrophils, showing that cell-
intrinsic disruption of clock regulators blunts diurnal fluctuation in granularity. Curves are repeated 
for two cycles (dashed line) to better appreciate the circadian pattern; n = 10 (WT), 3 (CXCR2∆N), 
4 (CXCR4∆N) and 4 (Bmal1∆N) mice per time point. c, Kinetics of total (top) or aged (bottom) 
neutrophils in blood indicating times of release of young or accumulation of aged neutrophils; n = 
5 mice (ZT13, ZT17, ZT21, ZT1 and ZT9), n = 4 mice (ZT5). d, Shift of the light cycle alters the 
pattern of granule content in neutrophils. Left, representative confocal images of sorted 
neutrophils (MPO, green; DAPI, blue; scale, 5 m); right, granule content per cell at the indicated 
times and light regime; n=3 mice. LD, light-dark cycle; DL, dark-light (inverted) cycle. e, 
Representative confocal images (scale, 1 m) and f, quantification of granule content in 
neutrophils from the blood or tissues of WT mice, showing reduced granule counts in tissues 
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compared with blood; n = 30 (blood, lung and spleen), n = 27 (Liver) cells from 3 mice. Data are 
shown as mean ± SEM. *; p<0.05; ***, p<0.001; n.s., not significant, as determined by one-way 
ANOVA with Dunnet’s multiple comparison test (d), or using the amplitude vs. zero two-tailed t-





Extended Data Figure 3. CXCR2-deficient neutrophils are responsive to activating stimuli.  
a, Representative confocal images (scale, 2 m) and b, quantification of granule content (top) 
and MPO intensity (bottom) in CXCR2-deficient neutrophils upon LPS or PMA stimulation. 
Granule loss indicates that CXCR2-deficient neutrophils are responsive to inflammatory stimuli; 
n = 15 cells per group. Data are shown as mean ± SEM. **; p<0.01; ***, p<0.001, as determined 





Extended Data Figure 4. Regulation of circadian patterns by Bmal1.  
a, Representative confocal images (left) and quantification of granule content (right) in Bmal1-
deficient neutrophils at ZT13 (night) and ZT5 (day). n = 30-31 cells from 3 mice; scale 2 m. b, 
Ex vivo NET formation by Bmal1-deficient neutrophils at ZT5 and ZT13. Note that Bmal1-deficient 
neutrophils fail to display circadian oscillations in both granule and NET formation. n = 3 mice per 
time point. c, Experimental design of circadian proteomic analysis of Bmal1-deficient neutrophils. 
d, Granule proteins (left) and NET-associated proteins (right) in the circadian Bmal1∆N neutrophil 
proteome (n = 3 mice at ZT5 and n = 2 at ZT13). Black dots show all granule or NET-associated 
proteins, respectively, none of which reached significance in differential expression between night 
and day (FDR<0.05, see methods section for TMT proteomics of mouse neutrophils). e, Heatmap 
of granule proteins in the circadian proteome of wild-type (same as in Figure 1) and Bmal1∆N 
neutrophils. Note that the diurnal pattern is lost in Bmal1-deficient neutrophils. Data in (a-b) are 






Extended Data Figure 5. Normal circadian oscillations in Balb/c mice.  
a, Total (left) and CD62LO aged (right) neutrophil counts in the blood of Balb/c mice; n = 4-5 mice 
per time. b, Circadian oscillations in CD62L and CXCR2 expression in neutrophils from Balb/c 
mice, measured as median fluorescence intensity (MFI) by flow cytometry n = 5 mice (ZT13, 
ZT17, ZT21, ZT1 and ZT9), n = 4 mice (ZT5). c, Side scatter values plotted together with surface 
levels of CD62L in neutrophils, showing similar fluctuation patterns as reported for C57BL/6 
neutrophils; n = 5 mice (ZT13, ZT17, ZT21, ZT1 and ZT9), n = 4 mice (ZT5). All curves are 
repeated for two cycles (dashed line) to better appreciate the circadian pattern. Data are shown 





Extended Data Figure 6. Neutrophils and platelets in the lung microvasculature during 
ALI.  
Quantification of neutrophil a, and platelet b, numbers per field of view over time in wild-type mice 
subject to ALI at night (ZT13, blue line) or during daytime (ZT5, red line), in the intravital imaging 
experiments shown in Figure 4c. Insets show area under the curve (AUC) values; n = 15 fields 
from 4 mice in each group. c, Neutrophil numbers in the lungs of naïve, LPS-only and wild-type 
mice in which ALI was induced at ZT5 (n = 8 mice) or ZT13 (n = 5 mice), or at ZT5 in the presence 
of Cl-amidine (n = 5 mice), as determined by flow cytometry. Neutrophils d, and platelets e, 
numbers in mutant mice (Bmal1∆N purple line; CXCR4∆N blue line) from the intravital imaging 
experiments shown in Figure 5d; n = 15 fields from 4 mice in each genotype. Insets show area 
under the curve (AUC) values. f, Neutrophil numbers in the lungs of LPS-only control mice (n = 
5) or during ALI in Bmal1N (n = 4 mice) or Cre- control (n = 4 mice); and CXCR4N (n = 5 mice) 
or Cre- control mice (n = 4 mice), as determined by flow cytometry. g, Interactions between 
platelets and the uropod (U) or leading edge (LE) of adherent neutrophils, in the inflamed 
cremasteric microvessels of wild-type (n = 45 from 3 mice), Bmal1N (n = 28 from 3 mice) and 
CXCR4N mice (n = 31 from 3 mice); scale, 5 m. Data are shown as mean ± SEM. **; p<0.01; 
***, p<0.001; n.s., not significant, as determined by unpaired two-tailed t-test analysis (a-d) or 
one-way ANOVA with Dunnet’s multiple comparison test (e-g). In the insets in a-d, individual data 
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points are not shown as this graph uses a mean ± SEM value for the area under the curve 





Extended Data Figure 7. Vascular leakiness and types of NETs during ALI.  
Vascular leakiness in a, wild-type, b, Bmal1∆N, and c, CXCR4∆N mice after induction of ALI (LPS 
+ antibody) or in control mice treated with LPS only. WT and Bmal1∆N mice displayed increased 
leakiness only in lungs upon ALI induction, while CXCR4∆N mice were protected; n = 3 (LPS only) 
and 5 (ALI) mice per genotype; d, Time-lapse images showing examples of flowing and adherent 
NETs (asterisks) as observed by intravital imaging of the lung microvasculature during ALI, 
representative of n = 3 independent experiments. See also Movie S5. e, Relative frequency of 
NET types in WT, Bmal1∆N and CXCR4∆N mice during ALI, n = 15 fields from 3 mice (WT), 10 
fields from 3 mice (Bmal1∆N) and 15 fields from 3 mice (CXCR4∆N). Data are shown as mean ± 
SEM. *; p<0.05; ***, p<0.001; n.s., not significant, as determined by two-way ANOVA (a-c; unless 






Extended Data Figure 8. Loss of circadian patterns in Bmal1∆N and CXCR4∆N mice.  
a, Survival of wild-type, Bmal1∆N and CXCR4∆N mice subjected to ALI at night (ZT13, solid line) 
or daytime (ZT5, dashed line); n = 16 mice (ZT5) and 18 mice (ZT13) for wild-type, n = 10 mice 
per time point for Bmal1∆N; n = 12 mice (ZT5) and 14 mice (ZT13) for CXCR4∆N. b, Representative 
confocal images (top) and quantification of granule content (bottom) in CXCR4-deficient 
neutrophils at ZT13 and ZT5. Note the loss of diurnal fluctuations compared with wild-type mice 
(see Figure 1e); n = 30 cells (from 3 mice) per time point; scale, 2 m. c, Ex vivo NET formation 
after PMA stimulation by CXCR4∆N neutrophils analyzed at ZT13 (n = 3 mice) and ZT5 (n = 3 
mice). Note the loss of diurnal changes in NET-formation compared with wild-type cells (see 
Figure 2b); d, Neutrophil counts in blood at ZT5 and ZT13 in wild-type (n = 5 mice at ZT5 and 4 
mice at ZT13) and Bmal1∆N mice (n = 4 mice per time point). Data are shown as mean ± SEM. *, 
p<0.05; **, p<0.01; n.s., not significant, as determined by two-sided log rank (Mantel-Cox) test (a) 






Extended Data Figure 9. Analysis of the human neutrophil proteome. 
a, Experimental design. Blood from 10 healthy volunteers was extracted at 8 am, 2pm and 7 pm. 
Neutrophils were purified for proteomic analysis, granule quantification and NET-formation 
assays. b, GO terms of the differentially expressed proteins between 8am and 2pm in human 
neutrophils. c, Correlation analysis (Spearman) of the direction of change of common proteins 
and genes from paired human proteomic (n = 5 per time) and RNA sequencing (n = 3 per time) 
analysis, showing poor correlation of RNA and protein content. d, Volcano plot of the human 
neutrophil proteome highlighting proteins found in NETs. Red dots and labels show proteins that 
are significantly different among samples (p <0.05), and black dots show all other NET proteins, 










Extended Data Figure 10. Graphical abstract. 
Neutrophils are released from the bone marrow into the bloodstream enriched in granule-held 
antimicrobial, cytotoxic and NET-forming proteins. As they spend time in the circulation, they 
undergo a homeostatic process of proteome “disarming” that is regulated by the clock gene Bmal1 
and signaling through CXCR2. This process causes a reduction in granule content and their ability 
to form NETs, ultimately reducing their toxicity towards host tissues. During acute lung injury, the 
presence of granule-poor neutrophils at specific times of day or in CXCR4 mutants protects the 
lungs and increases survival. Disabling homeostatic degranulation in Bmal1 mutants, in contrast, 




Legends for movies. 
 
Movie S1. 
Whole mount immunostaining of clarified lungs showing almost complete absence of NETs in 
naïve lungs before ALI induction. Lungs were stained for MPO (neutrophils), DNA, citrunillated-
histone 3 and CD31. NETs were defined as triple-positive MPO-DNA-citH3 events. 
Representative of 3 independently cleared lungs. 
Movie S2. 
Whole mount immunostaining of clarified lungs during ALI, showing abundant NETs scattered 
throughout the lung. Lungs were stained for MPO (neutrophils), DNA, citrunillated-histone 3 and 
CD31. NETs were defined as triple-positive MPO-DNA-citH3 events. Representative of 3 
independently cleared lungs. 
Movie S3. 
Intravital imaging of lungs during ALI, showing the formation of NET-like events in the 
pulmonary microvasculature. When ALI is induced at night (ZT13), more NET-like events 
(arrows) are produced compared with induction at noon (ZT5). Mice were treated intravenously 
with fluorescent anti-Ly6G to label neutrophils, and Sytox green for extracellular DNA. NET-like 
events are defined as those in which DNA is extruded from a neutrophil. Representative of 4 
independent mice per time. 
Movie S4. 
3D reconstruction of CT scans of lungs from WT, Bmal1∆N and CXCR4∆N mice before (t = 0) and 
after acute lung injury induction (t = 21). The appearance of edema is shown by fluid 
accumulation (red) in the lungs, and bones are shown for reference. Representative of 7 
independent mice per genotype. 
Movie S5. 
Intravital microscopy of the lung microcirculation showing the two identified types of NETs 
produced by neutrophils during ALI: Flowing NETs in which DNA is extruded out of the 
neutrophil body and is washed away by the blood flow; and adherent NETs, in which DNA is 
slowly extruded as the neutrophil crawls on the vessel, and adheres to the endothelial surface. 
Examples of both are shown. Representative of 9 independent experiments 
Movie S6. 
Video abstract. Neutrophils are released from the bone marrow into the bloodstream enriched in 
granule-held antimicrobial, cytotoxic and NET-forming proteins. As they spend time in the 
circulation, they undergo a homeostatic process of proteome “disarming” that is regulated by the 
clock gene Bmal1 and signaling through CXCR2. This process causes a reduction in granule 
content and their ability to form NETs, ultimately reducing their toxicity towards host tissues. 
During acute lung injury, the presence of granule-poor neutrophils at specific times of day or in 
CXCR4 mutants protects the lungs and increases survival. Disabling homeostatic degranulation 





Legends for supplementary tables. 
 
Table S1. 
Proteomic data (related to Figure 1) of night-like and day-like neutrophils. Protein Id, identifier of 
each protein. Z, Z-score (positive values indicate increased representation in night neutrophils); 
FDR, false discovery rate. From single samples of 60 million neutrophils polled from 9 mice 
(night) and 6 mice (day). See methods for 18O proteomics for details. 
Table S2. 
Full Gene Ontology (GO) Terms table, related to Supplementary Figure 1B and Table S1. 
Table S3. 
List of granule-held proteins and the granule type in which they are normally stored. 
Table S4. 
Proteomic data (related to Supplementary Figure 1D) of wild-type mouse neutrophils treated 
with AMD3100 (n = 3) or vehicle (n = 3) and sorted at ZT5. Protein Id, identifier of each protein. 
Columns 2-7: individual Z values. Integrated Z, integrated Z-score (positive values indicate 
increased representation in 8am neutrophils); FDR, false discovery rate. See methods for TMT 
proteomics of mouse neutrophils for details. 
Table S5. 
Proteomic data (related to Supplementary Figure 4D-E) of Bmal1∆N neutrophils at ZT13 (n = 2) 
and ZT5 (n = 3). Protein Id, identifier of each protein. Columns 2-6: individual Z values. 
Integrated Z, integrated Z-score (negative values indicate increased representation in night 
neutrophils); FDR, false discovery rate. See methods for TMT proteomics of mouse neutrophils 
for details. 
Table S6. 
Proteomic data (related to Figure 6) of human neutrophils at 8AM (n = 5) and 2PM (n = 5). 
Protein Id, identifier of each protein. Z, integrated Z-score (positive values indicate increased 
representation in 8am neutrophils); FDR, false discovery rate. See methods for TMT proteomics 
of human neutrophils for details. 
Table S7. 
Full Gene Ontology (GO) Terms table of the human proteomic data, related to Supplementary 
Figure 9B and Table S6. 
Table S8. 
Statistical parameters from the different quantitative proteomics experiments. 
 
